Trial Profile
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms BTXADMPPNP
- 06 Aug 2017 Status changed from recruiting to discontinued due to enrolling failure (lack of participants)
- 05 Jun 2015 New trial record